Bryan Roberts
Board Director
Pharmaceuticals
Hua Medicine
China
Biography
Bryan joined Venrock as a Kauffman Fellow in 1997. He is based in Venrock’s Palo Alto office and invests broadly across the healthcare industry. Bryan is currently Chairman of the Board of Directors of Achaogen (NASDAQ: AKAO), Castlight Health (NYSE: CSLT), Ironwood Pharmaceuticals (NASDAQ: IRWD) and Kyruus, in addition to serving on the Board of several other private companies. Past investments include Ariosa Diagnostics (acquired by Roche), athenahealth (NASDAQ: ATHN), Ikaria (acquired by Mallinkrodt), Illumina (NASDAQ: ILMN) and Sirna Therapeutics (acquired by Merck). Bryan was named a Henry Crown Fellow by the Aspen Institute in 2006 and has ranked on Forbes’ Midas List seven times, 2008 - 2015. Immediately prior to joining Venrock, Bryan received his Ph.D. in Chemistry & Chemical Biology from Harvard University. He previously held positions in corporate finance at Kidder, Peabody & Co and received his B.A. from Dartmouth College.
Research Interest
Business, Management, Finance, Pharmaceuticals, Pharmacology
